Helen Fisher

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Helen Fisher
Helen Fisher
Non-Executive Director / Paradigm Biopharmaceuticals

Helen Fisher is the chief executive and managing director of Bio Capital Impact Fund and a director of NovellusDx, a personalised cancer diagnostics company.

Prior to establishing the Bio Capital Impact Fund in 2017, Ms Fisher was a partner of Deloitte and led its life sciences industry practice in Australia for 5 years.

She has provided strategic tax advice to public-listed and large multinational companies and has extensive experience with capital raisings, licensing deals, demergers, implementing offshore structures, IP management and location, and supply chain management.

Lists and Charts

Roles

2020
Non-Executive Director
Calix
Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
1751st Future Battery Minerals">Future Battery Minerals -74.32% -24.21%
1752nd Intra Energy Corporation">Intra Energy Corporation -74.43% -29.74%
1753rd Calix">Calix -74.86% 2.38%
1754th Riedel Resources">Riedel Resources -74.93% -35.04%
1755th Krakatoa Resources">Krakatoa Resources -74.97% -23.47%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

30/11/23
Issued
Paradigm Biopharmaceuticals
30/11/23
$439 Issued
Paradigm Biopharmaceuticals
18/05/23
$10.02k Bought
Paradigm Biopharmaceuticals
Total value as at the date of the transaction
Powered by Morningstar ®

    Related Information

    Access to our data for Helen Fisher is only available to paid subscribers with Data & Insights access.

    Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

    Helen Fisher is linked to 5 organisations which are included in 1 list - Public Companies - non WA.

    To see the data you will need to Subscribe.

    X